| INTRODUCTION
Insulin resistance (IR) plays a central role in the pathogenesis of type 2 diabetes (T2D) and directly leads to hyperglycemia by interfering with insulin action. However, IR is not typically considered a contributor to the pathophysiology of type 1 diabetes (T1D), a disease where hyperglycemia stems primarily from insulin deficiency.
IR has been strongly implicated as a risk factor for cardiovascular disease in the general population as well as in individuals with T2D, and more recently in T1D. 1, 2 The presence of impaired insulin sensitivity (IS) has been well documented in adults with T1D 3,4 and our group has previously reported significant decreases in IS in normal weight youth with T1D when compared with healthy pubertal stage, body mass index (BMI), and activity matched controls. 5, 6 In this adolescent cohort, lower IS correlated with impaired functional exercise capacity and early markers of cardiovascular dysfunction, suggesting that morbidity from IR in T1D begins early in the disease process.
The phenotype of IR in youth with T1D, however, differs from youth with T2D, the latter being nearly universally obese, with pre- Moreover, the CACTI study did not find a correlation between IS and glycemic control as measured by HbA1c nor continuous glucose monitoring (CGM). 13 However, individuals in CACTI were selected to have much better glycemic control than the Arslanian study, as mean HbA1c was 7.5 AE 0.9%, and no youth were studied. Finally, there have been no comparisons between the role of hyperglycemia and IS in T1D vs T2D. The aim of this report, therefore, is to describe the relationship between IS and glycemia across a broader spectrum, as measured by HbA1c and CGM, in youth with T1D and T2D.
| RESEARCH DESIGN AND METHODS

| Participants
Adolescents with T1D and T2D were recruited from the University 
| CGM data
For each participant that wore a CGM, 48 hours of data, with an equal number of sensor values (ie, 576), were analyzed. Typical hours for daytime (6) (7) (8) (9) (10) (11) (12) and nighttime (12-6 AM) glucose distributions were determined.
Nighttime hours were selected to represent expected, average timeframes during which adolescents were most likely to be sleeping and not eating. 
| Statistical analysis
The distributions of all variables were examined prior to analysis.
Descriptive statistics were reported as mean and standard deviation for continuous variables with normal distributions and median (25th percentile, 75th percentile) for continuous variables with non-normal distributions. Groups were compared using t-tests, the Wilcoxon rank-sum test, chi-square tests, or Fisher's exact test, as appropriate. Spearman correlation coefficients were calculated for GIR and glycemic variables.
All analyses were performed using SAS for Windows (version 9.4).
| RESULTS
One hundred forty-two adolescents were included in the analysis.
One hundred had T1D and 42 had T2D. Baseline characteristics of both groups are presented in 6 and, as expected, the youth with T2D had lower IS than those with T1D.
CGM data (Table 1) were available in a consecutively enrolled subgroup of the overall cohort, as this data collection was added to the protocol later in the course of the primary study when funding became available. Baseline characteristics of the CGM subgroup were similar to that seen in the overall cohort. Youth with T1D compared with those with T2D had a greater degree of hyperglycemia (as reflected by average sensor glucose, peak sensor glucose, area under the curve, time spent >200), greater glucose variability (standard deviation), and more hypoglycemia. Table 2 Correlations between glycemia as measured by CGM and GIR are presented in Table 3 . In youth with T2D, higher average sensor glucose and glucose area under the curve correlate with lower IS. Maximum sensor glucose also tended to (P = .05) correlate with lower IS. In youth with T1D, however, higher overnight glucoses-as represented by night average, maximum, and minimum sensor glucose and by area under the CGM glucose curve-predicted greater IS. Furthermore, more time spent in hyperglycemia >200 mg/dL also predicted greater IS while more time spent hypoglycemic <70 mg/dL predicted decreased IS. 
| DISCUSSION
We found that youth with T1D, in contrast to youth with T2D, have paradoxically improved IS in the face of hyperglycemia. By using CGM to measure glycemic variations, a novel finding of this study is . Yki-Jarvinen et al. described lower GIR by hyperinsulinemic-euglycemic clamp in males with T1D following exposure to a period of prolonged hyperglycemia. From these data, the authors concluded that hyperglycemia induced IR. However, counter-regulatory hormones were also higher at clamp start after the blood glucose dropped to euglycemia following hyperglycemia, and the degree to which these hormones contributed to impairment in IS in their study was not determined. 8, 20 The concept that chronic hyperglycemia induces IR has been derived from various studies documenting (1) an inverse correlation between IS and glycated hemoglobin, 9 (2) improvement of insulin action with improved glycemic control via continuous subcutaneous insulin infusion (CSII), 21, 22 and (3) decreases in insulin-mediated glucose disposal with experimentally induced hyperglycemia. 8 In the study by Arslanian et al., 9 youth with T1D and HbA1 levels >10.4%
had lower IS as measured by hyperinsulinemic-euglycemic clamp than those with HbA1 levels <10.4%, although notably, the youth with higher HbA1 also had significantly higher growth hormone concentra- The association between hyperglycemia (% time >200 mg/dL on CGM) and improved IS observed in these T1D youth may also be a reflection of underinsulinization, as increased peripheral insulin has been associated with down-regulation of peripheral insulin receptors. 23, 24 Hyperinsulinemia-induced IR has been described in mice transfected with extra copies of the insulin gene leading to insulin excess, and in vivo studies in humans have induced lower IS after exposure to hyperinsulinemia.
24-26
Loss of endogenous insulin secretion into the portal circulation and peripheral exogenous insulin replacement also lead to relative underinsulinization of the liver and overinsulinization of peripheral tissues. Endogenous insulin secretion typically results in portal vein insulin concentrations three times higher than that seen peripherally and subcutaneous insulin alone is insufficient to restore this gradient. 27 A study of combined kidney-pancreas transplantation compared different anastomoses of the pancreatic vein and described lower peripheral tissue IS with systemic anastomoses vs portal anastomoses. 28 Another study in T1D patients found normalization of IS at both the hepatic and skeletal muscle level after undergoing intrahepatic islet transplantation, despite being on low-doses of immunosuppressive agents, 29 demonstrating the importance of adequate hepatic concentrations of insulin on IS. From these studies, one could hypothesize that higher overnight fasting glucoses are a reflection of increased hepatic glucose output, so that increased basal insulin doses correlate with lower hepatic glucose output. This hypothesis could explain why those with the lowest overnight glucoses in our study may in fact have the greatest peripheral hyperinsulinization and thus more IR.
Of note, in our cohort, a relationship between hypoglycemia and IS was not demonstrated in youth with T2D. One potential explanation is that our participants with T2D had minimal hypoglycemia detected on CGM as very few of the T2D youth were on insulin therapy. Another likely factor is that in T2D, IR combined with relative insulin deficiency causes hyperglycemia; thus, it is expected that IR and hyperglycemia would correlate in T2D. In contrast, in T1D, hyperglycemia occurs primarily from absolute insulin deficiency. Thus, the differing pathologic mechanisms influencing glycemia in these two populations likely contribute to the differences in our findings.
Furthermore, hypoglycemia starts at a young age in children with T1D and despite newer insulin analogs, insulin pump therapy, and CGM technology, rates of hypoglycemia remain high. [30] [31] [32] The potential long-term impacts of these early, recurrent events on IS require further study.
Limitations of our study include the small number of participants with CGM data. These data are exploratory and findings from this subgroup should be considered hypothesis-generating. Despite the small numbers, a consistent pattern between glycemia and IS in T1D
youth, that differed from T2D youth, was demonstrated. Furthermore, multiple significant correlations between glycemia as measured by CGM and IS were found. Also, when considering glucose extremes, in this study, while the HbA1c range was much wider than in the CACTI study, youth with HbA1c >12% were still excluded, therefore, the role of marked hyperglycemia in IS was not assessed in this study. It is possible that marked hyperglycemia may be associated with impaired IS, however, further studies would be needed to isolate glucose effects from other consequences of insulin deficiency and metabolic instability. Although we postulate several mechanisms other than hyperglycemia to explain the lower IS detected in T1D
youth, further studies including measures of counter-regulatory hormones are required to explore these hypotheses and larger studies are needed to verify these findings. Stable isotope tracer studies to determine the relationship between hyperglycemia and hepatic and adipose IR are also underway.
In conclusion, our findings suggest that hyperglycemia alone is not responsible for the impairments in IS seen in adolescents with T1D. CGM outcomes in this study provide evidence for alternate etiologies of IR, such as hypoglycemia, although the true mechanisms require further study. Last, IR is present in T1D, regardless of glucose control and despite current technology and modes of insulin delivery, implying a need for non-insulin agents in these youth to improve IS and its associated morbidity. 
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